The Centers for Disease Control and Prevention’s (CDC’s) Healthcare Infection Control Practices Advisory Committee offered information on ways to reduce the risk for transmission multidrug-resistant organisms and other emergent pathogens, according to an article on the Health Facilities Management website.
C. difficile, for instance, is a tremendous source of mortality and morbidity to the healthcare delivery system.
The CDC recommendations for C. difficile include:
• Isolating patients with suspected or confirmed C. difficile disease immediately.
• Collaborating with the facility’s ES professionals to ensure that room surfaces are cleaned thoroughly on a daily basis and also upon discharge. It is important to use an EPA-approved, spore-killing disinfectant for units where there is potential transmission.
Strategies for Success with Life Sciences and Healthcare Projects
Building Disaster Resilience Through Collaboration
Archer Acquires MemorialCare-Anchored Orange County Medical Office Portfolio
Life Sciences and Healthcare: Reshaping Institutional Design
Arnprior Regional Health Upgrades Building Controls to Improve IEQ